This one-hour session that convenes key opinion leaders to address critical scientific and translational challenges, including:
Optimization and large-scale production of stem cell–derived islets for human implantation
Clinical trial design and regulatory considerations
Immunosuppression strategies versus beta-cell engineering and immune evasion
Selection and optimization of implantation sites and devices.
Host: Monica Westley, PhD, Founder the(sugar)science
Panelists:
Camillo Ricordi, MD, Univ of Miami Diabetes Research Institute (DRI)
Matthias von Herrath, PhD & VP, DRI & Novo Nordisk
William Rust, PhD CEO, Seraxis
Bart Roep, PhD, Leiden University Medical Center (LUMC)
Guy Rutter, PhD, University of Montreal
Steve Perrin, PhD CSO, Eledon Pharmaceuticals
FULL VIDEO:
